 |
ToxChats©Author: ACT ToxChats Language: en Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Discussing the FDA's Announcement to Phase Out Animal Testing in Monoclonal Antibody Development
Thursday, 17 July, 2025
This podcast episode is designed to offer listeners a discussion about the FDA’s evolving stance on animal testing and exploring thoughts on its potential phase-out for monoclonal antibody (mAb) therapies. Hosted by Zac Lloyd and featuring expert insights from Dr. Whitney Helms, Executive Director of Nonclinical Development, Large Molecule Discovery at Eli Lilly and Company, and Dr. Diann Blanset, consultant at Akkeri, Inc., this roundtable-style discussion unpacks the scientific, ethical, and regulatory implications of this paradigm shift. Whether you're deep in the biologics pipeline or navigating the changing CRO landscape, this episode offers valuable perspectives on what the future may hold—and how to prepare for it.
